Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 10.24
(0.29%)
CNY 10.24
(0.29%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 953.98 Million CNY | -12.29% |
| 2022 | 1.08 Billion CNY | 12.15% |
| 2021 | 969.84 Million CNY | 29.15% |
| 2020 | 750.94 Million CNY | -2.9% |
| 2019 | 773.33 Million CNY | 11.39% |
| 2018 | 694.25 Million CNY | 1.84% |
| 2017 | 681.71 Million CNY | 7.66% |
| 2016 | 633.18 Million CNY | 21.32% |
| 2015 | 521.91 Million CNY | 14.93% |
| 2014 | 454.12 Million CNY | 11.82% |
| 2013 | 406.12 Million CNY | 23.04% |
| 2012 | 330.08 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 177.32 Million CNY | -0.56% |
| 2024 Q2 | 264.37 Million CNY | 49.09% |
| 2024 Q3 | 219.14 Million CNY | -17.11% |
| 2023 FY | 953.98 Million CNY | -12.29% |
| 2023 Q2 | 317.15 Million CNY | 51.92% |
| 2023 Q3 | 249.75 Million CNY | -21.25% |
| 2023 Q4 | 178.31 Million CNY | -28.6% |
| 2023 Q1 | 208.75 Million CNY | -4.43% |
| 2022 Q3 | 344.69 Million CNY | 25.2% |
| 2022 Q2 | 275.32 Million CNY | 10.48% |
| 2022 Q1 | 249.21 Million CNY | 10.97% |
| 2022 FY | 1.08 Billion CNY | 12.15% |
| 2022 Q4 | 218.43 Million CNY | -36.63% |
| 2021 Q4 | 224.57 Million CNY | -22.89% |
| 2021 Q1 | 214.65 Million CNY | 2.66% |
| 2021 FY | 969.84 Million CNY | 29.15% |
| 2021 Q2 | 239.37 Million CNY | 11.52% |
| 2021 Q3 | 291.23 Million CNY | 21.66% |
| 2020 Q2 | 202.48 Million CNY | 101.72% |
| 2020 Q3 | 238.99 Million CNY | 18.03% |
| 2020 FY | 750.94 Million CNY | -2.9% |
| 2020 Q1 | 100.37 Million CNY | -45.47% |
| 2020 Q4 | 209.08 Million CNY | -12.52% |
| 2019 Q3 | 224.43 Million CNY | 10.74% |
| 2019 Q2 | 202.67 Million CNY | 25.0% |
| 2019 Q1 | 162.13 Million CNY | -5.88% |
| 2019 FY | 773.33 Million CNY | 11.39% |
| 2019 Q4 | 184.09 Million CNY | -17.97% |
| 2018 Q4 | 172.25 Million CNY | -14.63% |
| 2018 Q1 | 156.41 Million CNY | 0.12% |
| 2018 FY | 694.25 Million CNY | 1.84% |
| 2018 Q2 | 163.81 Million CNY | 4.73% |
| 2018 Q3 | 201.78 Million CNY | 23.18% |
| 2017 Q1 | 146.98 Million CNY | -4.68% |
| 2017 FY | 681.71 Million CNY | 7.66% |
| 2017 Q4 | 156.22 Million CNY | -22.04% |
| 2017 Q3 | 200.4 Million CNY | 12.52% |
| 2017 Q2 | 178.09 Million CNY | 21.17% |
| 2016 FY | 633.18 Million CNY | 21.32% |
| 2016 Q2 | 153.85 Million CNY | 10.7% |
| 2016 Q3 | 186.12 Million CNY | 20.97% |
| 2016 Q1 | 138.99 Million CNY | 1.97% |
| 2016 Q4 | 154.2 Million CNY | -17.15% |
| 2015 Q4 | 136.31 Million CNY | 0.0% |
| 2015 Q2 | 124.64 Million CNY | -0.0% |
| 2015 Q1 | 124.64 Million CNY | 1.2% |
| 2015 FY | 521.91 Million CNY | 14.93% |
| 2015 Q3 | 136.31 Million CNY | 9.36% |
| 2014 Q1 | 103.89 Million CNY | 0.0% |
| 2014 Q2 | 103.89 Million CNY | 0.0% |
| 2014 FY | 454.12 Million CNY | 11.82% |
| 2014 Q3 | 123.16 Million CNY | 18.55% |
| 2014 Q4 | 123.16 Million CNY | 0.0% |
| 2013 FY | 406.12 Million CNY | 23.04% |
| 2012 FY | 330.08 Million CNY | 0.0% |